@FierceMedDev: ICYMI from FierceDiagnostics: CombiMatrix coasts toward growth with renewed sales push. Report | Follow @FierceMedDev
@StacyALawrence: Go big or go home: A call for FierceMedicalDevices' 2015 Fierce 15 nominations. ICYMI | Follow @StacyALawrence
@EmilyWFierce: Natera joins forces with University College London for lung cancer study. FierceDiagnostics story | Follow @EmilyWFierce
> Stealthy Stanford neuromodulation startup Nalu Medical raises $11.9 million in its first reported institutional round. SEC filing
> Royal Philips ($PHG) has built the first fully digital diagnostic capability for Dutch clinical pathology laboratory LabPON. More
> Sorin has launched FlexTherm--the latest heating and cooling system to integrate with its heart-lung machine for use during open-heart surgery that requires cardiopulmonary bypass. More
Biotech News
@FierceBiotech: 21st Century drug bill triggers a DC dust-up over relaxed development regs. Report | Follow @FierceBiotech
@JohnCFierce: EuroBiotech: KDEV halves portfolio value, U.K. life sci funding hits 10-year high, CF gene therapy on the block. Report | Follow @JohnCFierce
@DamianFierce: ICYMI: Patrick Soon-Shiong tacitly creates another company every time he does anything. NantKwest?! Release | Follow @DamianFierce
> Sanofi cozies up to top-tier labs with new R&D partnering effort. News
> Third Rock's GBT swings for a $115M IPO to push its pill for sickle cell. Article
> Woodford backs ReNeuron's $106M fundraise for cell therapy R&D. Report
Pharma News
@FiercePharma: ImmuCell boosts Q2 sales guidance as inventory management improves. FierceAnimalHealth article | Follow @FiercePharma
@EricPFierce: FDA says China staffer Dr. Lixia Wang was key to negotiating deal for more FDA inspection staff in China. More from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: AstraZeneca grabs $215M for GI drug rights in latest cash-generating deal. Article | Follow @CarlyHFierce
> Novartis' pay-for-performance Entresto plan has its critics--Express Scripts' Miller among them. Story
> U.K. cost gatekeeper changes its tune on Entyvio for Crohn's. More
> Fresenius companies fined £550,000 by U.K. court in patient death. News